X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/intellia-exits-hemophilia-pact-with-regeneron-sangamo-targets-24m-raise/
https://www.globenewswire.com/news-release/2024/03/18/2847698/0/en/Intellia-Therapeutics-Announces-First-Patient-Dosed-in-the-Phase-3-MAGNITUDE-Study-of-NTLA-2001-as-a-Single-Dose-CRISPR-Based-Treatment-for-Transthyretin-Amyloidosis-with-Cardiomyo.html
https://www.fool.com/investing/2024/03/09/is-intellia-therapeutics-stock-a-buy-now/
https://www.globenewswire.com//news-release/2024/02/22/2833580/0/en/Intellia-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Highlights-Recent-Company-Progress.html
https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-and-recode-therapeutics-announce-strategic
https://www.globenewswire.com//news-release/2024/02/14/2828990/0/en/Intellia-Therapeutics-to-Hold-Conference-Call-to-Discuss-Fourth-Quarter-and-Full-Year-2023-Earnings-and-Company-Updates.html
https://www.globenewswire.com/news-release/2024/01/31/2821597/0/en/Intellia-Therapeutics-Announces-Publication-of-Positive-Interim-Phase-1-Data-for-NTLA-2002-in-Patients-with-Hereditary-Angioedema-in-the-New-England-Journal-of-Medicine.html
https://endpts.com/intellia-therapeutics-cuts-15-of-workforce-extends-cash-runway-into-mid-2026/
https://www.globenewswire.com//news-release/2024/01/04/2804303/0/en/Intellia-Therapeutics-Highlights-its-Three-Year-Strategic-Priorities-and-Anticipated-2024-Key-Milestones.html
https://www.fiercebiotech.com/biotech/layoffs-hit-crispr-company-intellia-and-delivery-startup-aera
Market Place
Share 
